Timeline

Voting rights breakdown

Gemeldete wirtschaftlich Berechtigte · 6

Eine einzelne, gemeinsam eingereichte Meldung: Der Stimmrechtsanteil gilt für die gesamte Gruppe, nicht für jede Person.

• Venture Incubator AG42.06%
• Alain Nicod42.06%
• Diego Braguglia42.06%
• Daniel Gutenberg42.06%
• Arnd Kaltofen42.06%
• Johann Mächler42.06%

Notice details

Beneficial owner

Venture Incubator AG

Each investor has undertaken severally, not jointly, to exchange its shares in Kuros against shares in Cytos as outlined in the combination agreement between Cytos and Kuros dated December 1, 2015, and subject to the terms and conditions set forth therein. At the closing of the transaction, Cytos is expected to issue between 353,006,886 new registered shares (assuming 90% of Kuros shares are exchanged for new Cytos shares) and 392,229,873 new registered shares (assuming 100% of Kuros shares are exchanged for new Cytos shares). Accordingly, the number of shares/voting rights pursuant to the entry in the commercial register will be between 461,022,162 and 500,245,149 at the time the investors will actually become shareholders in Cytos. It is expected that the investors will hold between 9.08% and 9.86% total equity securities and purchase positions post closing. VI Partners AG is a shareholder and the management company of Venture Incubator AG, a multi-investor investment company. Messrs. Nicod, Braguglia, Gutenberg, Kaltofen and Mächler are shareholders of VI Partners AG.